Minor
DT120 for Generalized Anxiety Disorder (Voyage)
Study completion pushed from Nov 2026 to Apr 2027
Definium Therapeutics US, Inc.Phase 3 NCT06741228 Registry history of NCT06741228 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Study completion pushed from Nov 2026 to Apr 2027
Definium Therapeutics US, Inc.Phase 3 NCT06741228 Registry history of NCT06741228 on ClinicalTrials.gov (opens the registry)
| Phase 2 | 1 | |
| Phase 3 | 4 |
Anxiety (2) · Depression (2)